A case of autoimmune haemolytic anaemia after 39 cycles of nivolumab
Sign Up to like & getrecommendations! Published in 2018 at "BMJ Case Reports"
DOI: 10.1136/bcr-2018-224608
Abstract: With growing use of nivolumab, rare but serious side effects have surfaced in some patients. We present a case of autoimmune haemolytic anaemia that developed after 39 cycles of nivolumab. A 78-year-old man with metastatic… read more here.
Keywords: cycles nivolumab; haemolytic anaemia; case; autoimmune haemolytic ... See more keywords
A Rare Case of Autoimmune Demyelinating Polyneuropathy and Hydrocephalus Secondary to Pembrolizumab
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Investigative Medicine High Impact Case Reports"
DOI: 10.1177/2324709620916358
Abstract: Pembrolizumab is a humanized monoclonal antibody that targets the programmed cell death 1 protein (PD-1) receptor and blocks the inhibitory checkpoint interaction between PD-1 and its ligands. This interaction leads to the upregulation of effector… read more here.
Keywords: rare case; demyelinating polyneuropathy; case; autoimmune demyelinating ... See more keywords
A Case of Autoimmune Pulmonary Alveolar Proteinosis that Improved after a COVID-19 Episode.
Sign Up to like & getrecommendations! Published in 2023 at "Internal medicine"
DOI: 10.2169/internalmedicine.1592-23
Abstract: Autoimmune pulmonary alveolar proteinosis (APAP) is caused by macrophage dysfunction owing to the presence of anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies. A 77-year-old man with APAP was referred to our hospital for whole-lung lavage (WLL) due… read more here.
Keywords: pulmonary alveolar; alveolar proteinosis; apap; autoimmune pulmonary ... See more keywords